[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2021013602A - Inhibidores de jak. - Google Patents

Inhibidores de jak.

Info

Publication number
MX2021013602A
MX2021013602A MX2021013602A MX2021013602A MX2021013602A MX 2021013602 A MX2021013602 A MX 2021013602A MX 2021013602 A MX2021013602 A MX 2021013602A MX 2021013602 A MX2021013602 A MX 2021013602A MX 2021013602 A MX2021013602 A MX 2021013602A
Authority
MX
Mexico
Prior art keywords
jak inhibitors
jak
inhibitors
disorders
diseases
Prior art date
Application number
MX2021013602A
Other languages
English (en)
Inventor
Jason Harris
Raju Mohan
John Nuss
Shendong Yuan
Original Assignee
Vimalan Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vimalan Biosciences Inc filed Critical Vimalan Biosciences Inc
Publication of MX2021013602A publication Critical patent/MX2021013602A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

En el presente documento se describen los inhibidores de la cinasa de Jano JAK para el tratamiento de enfermedades, trastornos o afecciones. También se describen composiciones farmacéuticas que contienen tales compuestos.
MX2021013602A 2019-05-08 2020-05-07 Inhibidores de jak. MX2021013602A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962845119P 2019-05-08 2019-05-08
US201962884588P 2019-08-08 2019-08-08
PCT/US2020/031925 WO2020227563A1 (en) 2019-05-08 2020-05-07 Jak inhibitors

Publications (1)

Publication Number Publication Date
MX2021013602A true MX2021013602A (es) 2022-04-06

Family

ID=73051620

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021013602A MX2021013602A (es) 2019-05-08 2020-05-07 Inhibidores de jak.

Country Status (13)

Country Link
US (1) US11136329B2 (es)
EP (1) EP3966209A4 (es)
JP (1) JP2022532877A (es)
KR (1) KR20220052859A (es)
CN (1) CN114269734A (es)
AU (1) AU2020267661A1 (es)
BR (1) BR112021022380A2 (es)
CA (1) CA3139277A1 (es)
IL (1) IL287876A (es)
MX (1) MX2021013602A (es)
SG (1) SG11202112362YA (es)
TW (1) TW202108587A (es)
WO (1) WO2020227563A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021013602A (es) 2019-05-08 2022-04-06 Vimalan Biosciences Inc Inhibidores de jak.
BR112022002390A2 (pt) 2019-08-08 2022-06-14 Vimalan Biosciences Inc Inibidores de jak
CN114644633A (zh) * 2020-12-18 2022-06-21 北京诺诚健华医药科技有限公司 杂环类jak抑制剂
KR102637915B1 (ko) * 2021-06-25 2024-02-19 한국화학연구원 유비퀴틴 프로테오좀 경로를 통해 비티케이 분해작용을 가지는 신규한 이작용성 헤테로사이클릭 화합물과 이의 용도
US12084453B2 (en) 2021-12-10 2024-09-10 Incyte Corporation Bicyclic amines as CDK12 inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1931674B1 (en) 2005-09-30 2012-12-12 Vertex Pharmaceuticals Incorporated Deazapurines useful as inhibitors of janus kinases
JO3235B1 (ar) 2006-05-26 2018-03-08 Astex Therapeutics Ltd مركبات بيررولوبيريميدين و استعمالاتها
US20110281821A9 (en) 2007-01-30 2011-11-17 Biogen Idec Ma Inc. Modulators of Mitotic Kinases
KR20130066703A (ko) 2008-02-06 2013-06-20 노파르티스 아게 피롤로［２,３­ｄ］피리미딘 및 티로신 키나제 억제제로서 그의 용도
EP2491039A1 (en) 2009-10-20 2012-08-29 Cellzome Limited Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
EP2566867A1 (en) * 2010-04-30 2013-03-13 Cellzome Limited Pyrazole compounds as jak inhibitors
WO2012143320A1 (en) 2011-04-18 2012-10-26 Cellzome Limited (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors
EP2760863A1 (en) * 2011-09-20 2014-08-06 Cellzome Limited Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors
MD20140130A2 (ro) 2012-06-29 2015-04-30 Pfizer Inc. 4-(amino-substituite)-7H-pirolo[2,3-d]pirimidine noi ca inhibitori de LRRK2
WO2016208595A1 (ja) * 2015-06-22 2016-12-29 小野薬品工業株式会社 Ｂｒｋ阻害化合物
CN108864057B (zh) * 2017-05-16 2020-03-31 山东大学 含有4-氨基吡唑结构的jak与hdac双靶点抑制剂及其制备方法和应用
MX2021013602A (es) 2019-05-08 2022-04-06 Vimalan Biosciences Inc Inhibidores de jak.
BR112022002390A2 (pt) 2019-08-08 2022-06-14 Vimalan Biosciences Inc Inibidores de jak

Also Published As

Publication number Publication date
BR112021022380A2 (pt) 2022-03-22
JP2022532877A (ja) 2022-07-20
TW202108587A (zh) 2021-03-01
SG11202112362YA (en) 2021-12-30
EP3966209A4 (en) 2023-01-04
CN114269734A (zh) 2022-04-01
KR20220052859A (ko) 2022-04-28
AU2020267661A1 (en) 2021-12-23
EP3966209A1 (en) 2022-03-16
CA3139277A1 (en) 2020-11-12
US11136329B2 (en) 2021-10-05
US20200369669A1 (en) 2020-11-26
IL287876A (en) 2022-01-01
WO2020227563A1 (en) 2020-11-12

Similar Documents

Publication Publication Date Title
MX2023004923A (es) Compuestos heterociclicos como inmunomoduladores.
MX2021009246A (es) Inmunomoduladores, composiciones y metodos de los mismos.
MX2023004593A (es) Inhibidores de tirosina cinasa 2 (tyk2) y usos de los mismos.
MX2022004390A (es) Aminas biciclicas como inhibidores de la cinasa dependiente de ciclina 2 (cdk2).
MX2021013602A (es) Inhibidores de jak.
MX2022002877A (es) Antagonistas de cinasa progenitora hematopoyetica 1 (hpk1) y sus usos.
EP3848370A3 (en) Tyk2 inhibitors and uses thereof
MX2020014245A (es) Inhibidores de quinasas dependientes de ciclinas.
EP4338802A3 (en) Tyk2 inhibitors, uses, and methods for production thereof
MX2021011723A (es) Ligandos de pseudocinasa tyk2.
EP4327809A3 (en) Tyk2 inhibitors and uses thereof
NZ757081A (en) Somatostatin modulators and uses thereof
MX2022005563A (es) Ligandos de la pseudoquinasa tyk2.
MX2021009555A (es) Ligandos de pseudocinasa tyk2.
CR20230362A (es) Inhibidores de cdk2 y métodos de uso de los mismos
MX2023003677A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2023009682A (es) Inhibidores de tyk2 y sus usos.
MX2023009685A (es) Inhibidores de tyk2 y sus usos.
MX2023003678A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2022009762A (es) Moduladores del purinorreceptor 3 p2x (p2x3).
MX2020007586A (es) Proceso de fabricacion de moduladores de somatostatina.
MX2021006619A (es) Inhibidores de la tirosina quinasa, composiciones y sus metodos.
MX2022000712A (es) Moduladores de nlrp3.
CR20220216A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1
MX2023009723A (es) Inhibidores de tyk2 y sus usos.